Variant report
Variant | esv3430131 |
---|---|
Chromosome Location | chr1:152753939-152755058 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:1 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
LCE1E | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs115864593 | chr1:152753964-152753965 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs546144640 | chr1:152753983-152753984 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs559979712 | chr1:152754016-152754017 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs2879458 | chr1:152754039-152754040 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
5 | rs147964536 | chr1:152754062-152754063 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs568353248 | chr1:152754064-152754065 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs530869779 | chr1:152754075-152754076 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs141853440 | chr1:152754090-152754091 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs552953120 | chr1:152754138-152754139 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs577527465 | chr1:152754147-152754148 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs546708055 | chr1:152754174-152754175 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs544213986 | chr1:152754194-152754195 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs180770079 | chr1:152754311-152754312 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs199701162 | chr1:152754322-152754323 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs58706512 | chr1:152754323-152754324 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs560685173 | chr1:152754410-152754411 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs186027739 | chr1:152754412-152754413 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs537516066 | chr1:152754414-152754415 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs73016794 | chr1:152754427-152754428 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs545762392 | chr1:152754537-152754538 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs147098718 | chr1:152754545-152754546 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs138483259 | chr1:152754558-152754559 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs376711644 | chr1:152754585-152754586 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs374356307 | chr1:152754594-152754595 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs573188322 | chr1:152754601-152754602 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs11586156 | chr1:152754630-152754631 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs561921959 | chr1:152754669-152754670 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs79225270 | chr1:152754707-152754708 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs79361977 | chr1:152754708-152754709 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs531027296 | chr1:152754714-152754715 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs192135665 | chr1:152754752-152754753 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs564584852 | chr1:152754799-152754800 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs533312509 | chr1:152754804-152754805 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs546965004 | chr1:152754819-152754820 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs151091369 | chr1:152754825-152754826 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs566881596 | chr1:152754849-152754850 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs535701632 | chr1:152754874-152754875 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs183891447 | chr1:152754878-152754879 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs558165207 | chr1:152754879-152754880 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs529598787 | chr1:152754890-152754891 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs11205103 | chr1:152754916-152754917 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs369168951 | chr1:152754924-152754925 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs188649573 | chr1:152754944-152754945 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs543597578 | chr1:152754946-152754947 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs542868431 | chr1:152754980-152754981 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 21129771 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20409316 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 17899364 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21611746 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Osteosarcoma | 17242211 | CNVD |
Ovarian cancer | 17242211 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Schizophrenia | 18990708 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Plasma-cell dyscrasia | 16705089 | CNVD |
Myeloma | 17024118 | CNVD |
Cancer | 17060936 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Type 2 diabetes | 19141583 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Breast cancer | 21509527 | CNVD |
Bladder cancer | 21909424 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Gastrointestinal cancer | 16790693 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:152747800-152755400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
2 | chr1:152754000-152754200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr1:152754000-152754200 | Enhancers | NHDF-Ad | bronchial |
4 | chr1:152754200-152755400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr1:152754200-152755400 | Weak transcription | NHDF-Ad | bronchial |
6 | chr1:152754200-152756000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |